Absorbable stents for treatment of benign biliary strictures: long-term follow-up in the prospective Spanish registry
Authors:
- Spanish group BiELLA (SERVEI)S(Spanish group BiELLA (SERVEI)
- Jose A. GuirolaJGJose A. Guirola
- Enrique Alvarez-ArranzEAEnrique Alvarez-Arranz
- Jose UrbanoJUJose Urbano
- 27 March 2020
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 30 (8) , 4486-4495
Abstract
Objectives Benign strictures of the bile duct may be difficult to treat endoscopically due to altered bowel anatomy. Furthermore, recurrence of stenosis and symptoms remains high. The aim of the Spanish Prospective Registry BiELLA study was to investigate the safety and efficacy of absorbable stents in the treatment of benign biliary strictures and their outcomes on the medium and long-term follow-up. Methods A prospective, multicenter, observational, non-randomized study (the BiELLA study) was conducted from January 2014 to September 2018. One hundred fifty-nine patients with benign biliary strictures, mostly postsurgical, were enrolled for implantation of absorbable biliary stents in the 11 participating Spanish tertiary hospitals. The average patient follow-up was 45.4 ± 15.9 months (range, 12–60 months). The follow-up data included symptoms, biochemical parameters, and ultrasound images at 1, 6, and 12 months and then yearly for up to 60 months. Results The immediate technical and clinical success rates were 100%. In all patients, stent placement resulted in improvement of clinical symptoms and biochemical parameters. The primary mean patency for stent was 86.7, 79.6, and 78.9% at 12, 36, and 60 months, respectively (95% CI). Biliary restenosis and occlusion occurred in 40 (26.6%) patients. Of the 40 patients, 18 (12%) patients were treated with a second stent and 22 (14.6%) patients had operative repair of the recurrent strictures. There were no major complications associated with stent implantation. Conclusions Implantation of an absorbable polydioxanone biliary stent is safe and effective for treatment of benign biliary strictures refractory to balloon dilatation or other biliary intervention. Key Points • Percutaneous implantation of biodegradable prostheses for the treatment of benign postsurgical biliary strictures is a safe and effective procedure. • More than 75% of the patients presented patency of the stented biliary tree at 5 years follow-up. • Absorbable stents improved clinical symptoms and signs (jaundice, itching, fever), and laboratory parameters in a few days after stent placement.Keywords
This publication has 45 references indexed in Scilit:
- Endoscopic Management of Benign Bile Duct StricturesGastrointestinal Endoscopy Clinics of North America, 2013
- The current diagnosis and treatment of benign biliary strictureSurgery Today, 2012
- Use of fully covered self-expanding metal stents in benign biliary diseasesWorld Journal of Gastrointestinal Endoscopy, 2012
- Management of benign intrahepatic bile duct strictures: initial experience with polydioxanone biodegradable stentsEndoscopy, 2010
- Plastic or metal stents for benign extrahepatic biliary strictures: a systematic reviewBMC Gastroenterology, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Percutaneous treatment of benign bile duct stricturesEuropean Journal of Radiology, 2007
- Acute bile duct injurySurgical Endoscopy, 2003
- To Err is Human, But Should We Expect More From a Surgeon?Annals of Surgery, 2003
- Paclitaxel Inhibits Proliferation of Cell Lines Responsible for Metal Stent Obstruction:Investigative Radiology, 2002